Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

"Pfizer just released its list of side effects of its COVID-19 vaccine," multiple Facebook posts said Jan. 26 and 27. The posts included a purported list of 46 Pfizer-BioNtech COVID-19 vaccine side ...

Shares of Pfizer Inc. PFE rallied 1.09% to $26.91 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,071.17 and ...

Analyst Tim Anderson from Bank of America Securities reiterated a Hold rating on Pfizer (PFE – Research Report) and keeping the price target at ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

A Semafor analysis of government schedules showed little access for business executives, a freeze-out expected to reverse ...

S&P 500, Bank of America Corp, Microsoft Corporation, Apple Inc. Read Contrarian Outlook (Michael Foster)'s latest article on ...